人民卫生出版社系列期刊
ISSN 2096-2738 CN 11-9370/R

中国科技核心期刊(中国科技论文统计源期刊)
2020《中国学术期刊影响因子年报》统计源期刊
美国化学文摘社(CAS)数据库收录期刊
日本科学技术振兴机构(JST)数据库收录期刊

新发传染病电子杂志 ›› 2024, Vol. 9 ›› Issue (5): 64-67.doi: 10.19871/j.cnki.xfcrbzz.2024.05.012

• 病例报道 • 上一篇    下一篇

瘤型麻风误诊为变应性血管炎1例

朱倩1, 刘宇倩1, 黎静2, 蒋豆蔻1, 许宗严3, 李祥子1   

  1. 1.深圳市慢性病防治中心皮肤科,广东 深圳 518020;
    2.深圳市慢性病防治中心性病麻风病防控科,广东 深圳 518020;
    3.深圳市福田区慢性病防治院皮肤科,广东 深圳 518110
  • 收稿日期:2024-06-15 出版日期:2024-10-31 发布日期:2024-12-11
  • 通讯作者: 李祥子,Email:dr_lixz@163.com
  • 基金资助:
    深圳市卫生经济学会科研基金(202432)

Lepromatous leprosy misdiagnosed as allergic vasculitis:a case report

Zhu Qian1, Liu Yuqian1, Li Jing2, Jiang Doukou1, Xu Zongyan3, Li Xiangzi1   

  1. 1. Department of Dermatology, Shenzhen Center of Chronic Disease Prevention and Control, Guangdong Shenzhen 518020, China;
    2. Department of STD and Leprosy Control, Shenzhen Center of Chronic Disease Prevention and Control, Guangdong Shenzhen 518020, China;
    3. Department of Dermatology, Futian District Chronic Disease Prevention Institute, Guangdong Shenzhen 518110,China
  • Received:2024-06-15 Online:2024-10-31 Published:2024-12-11

摘要: 本文报道1例25岁女性患者,下肢红斑、溃疡3年,背部丘疹、结节半年,近3年多次于外院就诊均按“变应性血管炎”诊断和治疗,效果不佳。在深圳市慢性病防治中心经皮肤组织液及组织病理检查确诊为瘤型麻风(lepromatous leprosy,LL)。因患者HLA-B 13:01检测阳性,不宜口服氨苯砜,予利福平600mg/月、莫西沙星400mg/d、氯苯吩嗪300mg/月,外加氯苯吩嗪50mg/d联合化疗,同时使用甲泼尼龙预防面神经炎,治疗期间出现Ⅱ型麻风反应,加用沙利度胺治疗后症状缓解。目前仍在随访中,皮损较前明显消退。此病例提示临床仍需进一步加强医务人员的能力培训,及早发现麻风患者,降低漏诊误诊率。电生理检查、麻风杆菌核酸检测、血清学试验、多重生物标记试验(multiplex biomarker test, MBT)试剂盒等可能在早期识别麻风患者、减少诊断延迟中具有很大潜力。

关键词: 瘤型麻风, 变应性血管炎, 误诊

Abstract: This paper report a 25-year-old female patient with erythema and ulceration of lower extremities for 3 years, papules and nodules of back for 6 months. In the past 3 years, she was diagnosed and treated in other hospital for many times, all of which were diagnosed and treated according to "allergic vasculitis" with poor results. The patient was diagnosed as lepromatous leprosy (LL) by skin tissue fluid and pathological examination. Because the patient tested positive for HLA-B13:01, it was not appropriate to take dapsone orally. Rifampicin(600mg/m), moxifloxacin (400mg/d), and chlorphenphenazine(300mg/m, 50mg/d) were given treatment, while methylprednisolone was used to prevent facial neuritis. During treatment, type Ⅱ leprosy reaction occurred, and symptoms were relieved after the addition of thalidomide. At present, the follow-up is still in progress, and the skin lesions have subsided significantly. This case suggests that we still need to further strengthen the training of medical personnel, early detection of leprosy patients, reduce the rate of missed diagnosis and misdiagnosis.Electrophysiological examination, leprae nucleic acid detection, serological tests, MBT(multiplex biomarker test) kits, etc., may have great potential in early identification of leprosy patients and reduce diagnostic delay.

Key words: Lepra lepromatosa, Allergic vasculitis, Misdiagnosis

中图分类号: